• Go to navigation
  • Go to content
GastroSource

Astrazeneca Worldwide

  • AstraZeneca Websites
az.com

Main navigation

  • Home
  • Latest News
  • Scientific Resources
  • Publication Services
  • Patient Cases
  • Gi Topics
  • Congress Calendar
  • Congress Reports
  • For Your Patients
  • GastroSource FAQ
  • Newsletter
  • Contact Us

Welcome to GastroSource

AstraZeneca is pleased to welcome you to GastroSource, an international website for healthcare professionals with an interest in gastroenterology. GastroSource contains scientific and educational material. We hope you will find the site useful.

  • Features

    • GI Topics:

      Drug induced esophagitis usually resolves readily when causative agents are discontinued

      Drug induced esophagitis usually resolves readily when causative agents are discontinued8 March, 2010: The most important clinical step in the management of drug-induced esophagitis is to make the right diagnosis, according to a summary of published studies.

      In most cases, injury resolves within a few days without intervention. Usually the diagnosis can be made by history alone. However, there is a small but  clinically significant risk of persistent esophagitis and stricture formation when damage caused by an agent such as a nonsteroidal anti-inflammatory drug is exacerbated by concomitant gastroesophageal reflux disease.

      Read more

    • Patient Cases

      A rare case of duodenal pseudomelanosis

      A rare case of duodenal pseudomelanosis2 March, 2010: Mucosal pigmentation is rarely seen in the upper GI tract, but is well known in the colon and rectum. The diffuse dark mucosal stain of melanosis coli is a late manifestation of many years use of purgatives.

      Here is presented a rare case characterized endoscopically by dark specks in the small bowel mucosa, seen in the duodenum and further down into the jejunum.

      Read more

  • Latest News

    • Mar 10, 2010  : Acidic perfusion provokes DIS without heartburn in healthy individuals

      Researchers have found that, although weakly acidic solutions can provoke dilated intercellular spaces in healthy individuals after esophageal perfusion, most of these individuals do not experience heartburn or pain, suggesting that non-erosive reflux disease patients have other critical factors underlying their symptoms.

    • Mar 8, 2010  : IBD inpatients at increased risk for MRSA infection

      Hospitalized patients with inflammatory bowel disease are at increased risk for contracting methicillin-resistant Staphylococcus aureus infection compared with non-IBD gastrointestinal and general inpatients, show Canadian researchers.

    • Mar 5, 2010  : New celiac disease-specific quality of life questionnaire developed

      Researchers have developed a new instrument specifically for measuring quality of life in patients with celiac disease.

    • Mar 3, 2010  : Acidic perfusion provokes DIS without heartburn in healthy individuals

      Researchers have found that, although weakly acidic solutions can provoke dilated intercellular spaces in healthy individuals after esophageal perfusion, most of these individuals do not experience heartburn or pain, suggesting that non-erosive reflux disease patients have other critical factors underlying their symptoms.

    • Mar 1, 2010  : IBD inpatients at increased risk for MRSA infection

      Hospitalized patients with inflammatory bowel disease are at increased risk for contracting methicillin-resistant Staphylococcus aureus infection compared with non-IBD gastrointestinal and general inpatients, show Canadian researchers.

    more news

Not signed in



  • Register
  • Forgotten password?

Page tools

  • Print
  • Bookmark this page

Endoscopy Atlas

Interactive Atlas of Gastrointestinal Endoscopy

GI Topics:

Large retrospective study links GERD and atrial fibrillation

GerdQ Questionnaire

GerdQ Questionnaire

Interactive videos

Towards Better Endoscopic Description of Reflux Esophagitis and Barrett's Esophagus

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010